Austal Limited
Austal Limited (ASB.AX) Financial Performance & Income Statement Overview
Explore the financials of Austal Limited (ASB.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
Austal Limited (ASB.AX) Income Statement & Financial Overview
View the income breakdown for Austal Limited ASB.AX across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $751.25M | $717.66M | $810.01M | $775.02M |
| Cost of Revenue | $671.86M | $624.53M | $760.08M | $725.85M |
| Gross Profit | $79.39M | $93.12M | $49.93M | $49.17M |
| Gross Profit Ratio | $0.11 | $0.13 | $0.06 | $0.06 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $121.16M | $74.55M | $66.14M | $61.85M |
| Operating Expenses | $121.16M | $74.55M | $66.14M | $61.85M |
| Total Costs & Expenses | $793.02M | $699.08M | $826.22M | $787.70M |
| Interest Income | $1.99M | $1.91M | $1.007M | $777000.00 |
| Interest Expense | $12.46M | $6.57M | $6.65M | $5.81M |
| Depreciation & Amortization | $21.26M | $33.21M | $30.43M | $29.39M |
| EBITDA | -$20.51M | $51.79M | $14.23M | $16.71M |
| EBITDA Ratio | -$0.03 | $0.07 | $0.02 | $0.02 |
| Operating Income | -$41.77M | $18.57M | -$16.20M | -$12.68M |
| Operating Income Ratio | -$0.06 | $0.03 | -$0.02 | -$0.02 |
| Other Income/Expenses (Net) | $55.69M | $8.84M | $7.73M | $5.64M |
| Income Before Tax | $13.92M | $27.41M | -$8.48M | -$7.04M |
| Income Before Tax Ratio | $0.02 | $0.04 | -$0.01 | -$0.009 |
| Income Tax Expense | $11.07M | $15.39M | -$2.00M | $257000.00 |
| Net Income | $2.85M | $12.02M | -$6.48M | -$7.29M |
| Net Income Ratio | $0.004 | $0.02 | -$0.008 | -$0.009 |
| EPS | $0.008 | $0.03 | -$0.02 | -$0.02 |
| Diluted EPS | $0.008 | $0.03 | -$0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $361.22M | $361.11M | $360.99M | $360.92M |
| Weighted Avg Shares Outstanding (Diluted) | $365.82M | $361.11M | $360.99M | $360.92M |
Over the past four quarters, Austal Limited demonstrated steady revenue growth, increasing from $775.02M in Q2 2023 to $751.25M in Q4 2024. Operating income reached -$41.77M in Q4 2024, maintaining a consistent -6% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$20.51M, reflecting operational efficiency. Net income dropped to $2.85M, with EPS at $0.008. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan